Tumor-ActivatedTCRγδ+T Cells from Gastric Cancer Patients Induce the Antitumor Immune Response ofTCRαβ+T Cells via Their Antigen-Presenting Cell-Like Effects

Protective Immunosurveillance and Therapeutic Antitumor Activity of γδ T Cells Demonstrated in a Mouse Model of Prostate Cancer

(2014) Zhiyong Liu et al.   JOURNAL OF IMMUNOLOGY

Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity

(2013) Victoria L. Green et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Protective Role of the Inflammatory CCR2/CCL2 Chemokine Pathway through Recruitment of Type 1 Cytotoxic    T Lymphocytes to Tumor Beds

(2013) T. Lanca et al.   JOURNAL OF IMMUNOLOGY

The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner

(2012) Yong Yi et al.   JOURNAL OF HEPATOLOGY

Human    T Lymphocytes Are Licensed for Professional Antigen Presentation by Interaction with Opsonized Target Cells

(2012) N. Himoudi et al.   JOURNAL OF IMMUNOLOGY

Tumor-Infiltrating    T Lymphocytes Predict Clinical Outcome in Human Breast Cancer

(2012) C. Ma et al.   JOURNAL OF IMMUNOLOGY

Licensing of killer dendritic cells in mouse and humans: Functional similarities between IKDC and human blood γδ T-lymphocytes

(2012) John Anderson et al.   Journal of Immunotoxicology

Harnessing γδ T cells in anticancer immunotherapy

(2012) Dalil Hannani et al.   TRENDS IN IMMUNOLOGY

Searching for “signal 2”: costimulation requirements of γδ T cells

(2011) Julie C. Ribot et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Adoptive immunotherapy of cancer using ex vivo expanded human γδ T cells: A new approach

(2010) Pouneh Dokouhaki et al.   CANCER LETTERS

Targeting    T Lymphocytes for Cancer Immunotherapy: From Novel Mechanistic Insight to Clinical Application

(2010) A. Q. Gomes et al.   CANCER RESEARCH

A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells☆☆☆

(2010) Jun Nakajima et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Prolonged antigen survival and cytosolic export in cross-presenting human    T cells

(2010) S. Meuter et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Toll-like Receptors 3 and 7 Agonists Enhance Tumor Cell Lysis by Human    T Cells

(2009) H. Shojaei et al.   CANCER RESEARCH

Efficient Killing of Human Colon Cancer Stem Cells by    T Lymphocytes

(2009) M. Todaro et al.   JOURNAL OF IMMUNOLOGY

Cross-presenting human    T cells induce robust CD8+    T cell responses

(2009) M. Brandes et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD4+CD25+ Treg cells inhibit human memory    T cells to produce IFN-  in response to M tuberculosis antigen ESAT-6

(2008) L. Li et al.   BLOOD

Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

(2008) Kui Li et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Increased CD4+CD25+FOXP3+ Regulatory T Cells in Cancer Patients from Conversion of CD4+CD25– T Cells through Tumor-Derived Factors

(2008) Chaoming Mao et al.   ONKOLOGIE

NKG2D Ligands Expression and NKG2D-Mediated Cytotoxicity in Human Laryngeal Squamous Carcinoma Cells

(2008) X. M. Chen et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY